Catalyst Wire Dossier Catalyst Wire Dossier

Icotrokinra

JNJ-77242113 · Janssen Research & Development, LLC
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Icotrokinra, covering 2026-03-12 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced Participants With Active Psoriatic Arthritis [Phase 3]

See pricing